228 related articles for article (PubMed ID: 26900152)
1. Insight into Structure-Function Relationships and Inhibition of the Fatty Acyl-AMP Ligase (FadD32) Orthologs from Mycobacteria.
Guillet V; Galandrin S; Maveyraud L; Ladevèze S; Mariaule V; Bon C; Eynard N; Daffé M; Marrakchi H; Mourey L
J Biol Chem; 2016 Apr; 291(15):7973-89. PubMed ID: 26900152
[TBL] [Abstract][Full Text] [Related]
2. Ser/Thr Phosphorylation Regulates the Fatty Acyl-AMP Ligase Activity of FadD32, an Essential Enzyme in Mycolic Acid Biosynthesis.
Le NH; Molle V; Eynard N; Miras M; Stella A; Bardou F; Galandrin S; Guillet V; André-Leroux G; Bellinzoni M; Alzari P; Mourey L; Burlet-Schiltz O; Daffé M; Marrakchi H
J Biol Chem; 2016 Oct; 291(43):22793-22805. PubMed ID: 27590338
[TBL] [Abstract][Full Text] [Related]
3. The acyl-AMP ligase FadD32 and AccD4-containing acyl-CoA carboxylase are required for the synthesis of mycolic acids and essential for mycobacterial growth: identification of the carboxylation product and determination of the acyl-CoA carboxylase components.
Portevin D; de Sousa-D'Auria C; Montrozier H; Houssin C; Stella A; Lanéelle MA; Bardou F; Guilhot C; Daffé M
J Biol Chem; 2005 Mar; 280(10):8862-74. PubMed ID: 15632194
[TBL] [Abstract][Full Text] [Related]
4. The dual function of the Mycobacterium tuberculosis FadD32 required for mycolic acid biosynthesis.
Léger M; Gavalda S; Guillet V; van der Rest B; Slama N; Montrozier H; Mourey L; Quémard A; Daffé M; Marrakchi H
Chem Biol; 2009 May; 16(5):510-9. PubMed ID: 19477415
[TBL] [Abstract][Full Text] [Related]
5. Assay development for identifying inhibitors of the mycobacterial FadD32 activity.
Galandrin S; Guillet V; Rane RS; Léger M; N R; Eynard N; Das K; Balganesh TS; Mourey L; Daffé M; Marrakchi H
J Biomol Screen; 2013 Jun; 18(5):576-87. PubMed ID: 23364516
[TBL] [Abstract][Full Text] [Related]
6. Crystal structure of FadD32, an enzyme essential for mycolic acid biosynthesis in mycobacteria.
Li W; Gu S; Fleming J; Bi L
Sci Rep; 2015 Dec; 5():15493. PubMed ID: 26628098
[TBL] [Abstract][Full Text] [Related]
7. X-ray crystal structure of Mycobacterium tuberculosis beta-ketoacyl acyl carrier protein synthase II (mtKasB).
Sridharan S; Wang L; Brown AK; Dover LG; Kremer L; Besra GS; Sacchettini JC
J Mol Biol; 2007 Feb; 366(2):469-80. PubMed ID: 17174327
[TBL] [Abstract][Full Text] [Related]
8. Crystal structure of the Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein synthase III.
Scarsdale JN; Kazanina G; He X; Reynolds KA; Wright HT
J Biol Chem; 2001 Jun; 276(23):20516-22. PubMed ID: 11278743
[TBL] [Abstract][Full Text] [Related]
9. Structure of the Essential
Kuhn ML; Alexander E; Minasov G; Page HJ; Warwrzak Z; Shuvalova L; Flores KJ; Wilson DJ; Shi C; Aldrich CC; Anderson WF
ACS Infect Dis; 2016 Aug; 2(8):579-591. PubMed ID: 27547819
[TBL] [Abstract][Full Text] [Related]
10. The Pks13/FadD32 crosstalk for the biosynthesis of mycolic acids in Mycobacterium tuberculosis.
Gavalda S; Léger M; van der Rest B; Stella A; Bardou F; Montrozier H; Chalut C; Burlet-Schiltz O; Marrakchi H; Daffé M; Quémard A
J Biol Chem; 2009 Jul; 284(29):19255-64. PubMed ID: 19436070
[TBL] [Abstract][Full Text] [Related]
11. Mutations in the essential FAS II β-hydroxyacyl ACP dehydratase complex confer resistance to thiacetazone in Mycobacterium tuberculosis and Mycobacterium kansasii.
Belardinelli JM; Morbidoni HR
Mol Microbiol; 2012 Nov; 86(3):568-79. PubMed ID: 22994892
[TBL] [Abstract][Full Text] [Related]
12. Diarylcoumarins inhibit mycolic acid biosynthesis and kill Mycobacterium tuberculosis by targeting FadD32.
Stanley SA; Kawate T; Iwase N; Shimizu M; Clatworthy AE; Kazyanskaya E; Sacchettini JC; Ioerger TR; Siddiqi NA; Minami S; Aquadro JA; Grant SS; Rubin EJ; Hung DT
Proc Natl Acad Sci U S A; 2013 Jul; 110(28):11565-70. PubMed ID: 23798446
[TBL] [Abstract][Full Text] [Related]
13. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
Tomioka H
Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
[TBL] [Abstract][Full Text] [Related]
14. ACCase 6 is the essential acetyl-CoA carboxylase involved in fatty acid and mycolic acid biosynthesis in mycobacteria.
Kurth DG; Gago GM; de la Iglesia A; Bazet Lyonnet B; Lin TW; Morbidoni HR; Tsai SC; Gramajo H
Microbiology (Reading); 2009 Aug; 155(Pt 8):2664-2675. PubMed ID: 19423629
[TBL] [Abstract][Full Text] [Related]
15. New approaches to target the mycolic acid biosynthesis pathway for the development of tuberculosis therapeutics.
North EJ; Jackson M; Lee RE
Curr Pharm Des; 2014; 20(27):4357-78. PubMed ID: 24245756
[TBL] [Abstract][Full Text] [Related]
16. Mycolic acids: deciphering and targeting the Achilles' heel of the tubercle bacillus.
Nataraj V; Varela C; Javid A; Singh A; Besra GS; Bhatt A
Mol Microbiol; 2015 Oct; 98(1):7-16. PubMed ID: 26135034
[TBL] [Abstract][Full Text] [Related]
17. Toward the virtual screening of potential drugs in the homology modeled NAD+ dependent DNA ligase from Mycobacterium tuberculosis.
Singh V; Somvanshi P
Protein Pept Lett; 2010 Feb; 17(2):269-76. PubMed ID: 20214650
[TBL] [Abstract][Full Text] [Related]
18. Mechanistic and functional insights into fatty acid activation in Mycobacterium tuberculosis.
Arora P; Goyal A; Natarajan VT; Rajakumara E; Verma P; Gupta R; Yousuf M; Trivedi OA; Mohanty D; Tyagi A; Sankaranarayanan R; Gokhale RS
Nat Chem Biol; 2009 Mar; 5(3):166-73. PubMed ID: 19182784
[TBL] [Abstract][Full Text] [Related]
19. Drugs that inhibit mycolic acid biosynthesis in Mycobacterium tuberculosis.
Schroeder EK; de Souza N; Santos DS; Blanchard JS; Basso LA
Curr Pharm Biotechnol; 2002 Sep; 3(3):197-225. PubMed ID: 12164478
[TBL] [Abstract][Full Text] [Related]
20. The Molecular Genetics of Mycolic Acid Biosynthesis.
PaweŁczyk J; Kremer L
Microbiol Spectr; 2014 Aug; 2(4):MGM2-0003-2013. PubMed ID: 26104214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
